Pancreatic Cancer Research

ResearcherSouthwest Medical UniversityActive in the last 2 years

Xiaolin Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5831-2491; OpenAlex author ID A5103051694, A5135092402. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2025: 2 papers · 2026: 1 paper

Papers 3

  1. Ubiquitination-Associated Ductal-Fibroblast Crosstalk Shapes Tumor Progression and Prognosis in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1155/humu/1665552↗
  2. The Key Role of COA6 in Pancreatic Ductal Adenocarcinoma: Metabolic Reprogramming and Regulation of the Immune Microenvironment. Last author DOI 10.1111/jcmm.70685↗
  3. TSPAN4+ fibroblasts coordinate metastatic niche assembly through migrasome-driven metabolic reprogramming and stromal-immune crosstalk in pancreatic adenocarci… Last author DOI 10.3389/fimmu.2025.1594879↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lai Jiang · 3 shared papers, 2025–2026 · strength 0.74
  2. Shengke Zhang · 3 shared papers, 2025–2026 · strength 0.74
  3. Ziye Zhuang · 1 shared paper, 2026 · strength 0.29
  4. Yiping Fu · 1 shared paper, 2026 · strength 0.29
  5. Qingwen Hu · 1 shared paper, 2025 · strength 0.23
  6. Hao Chi · 1 shared paper, 2025 · strength 0.23
  7. Bo Li · 1 shared paper, 2025 · strength 0.23
  8. Hao Chi · 1 shared paper, 2025 · strength 0.22
  9. Hui Meng · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.